CSU Animal Cancer Center

Collaborating for a Cure! 💪

Beating cancer – in all species – will take the sharpest minds and biggest hearts. Recently, we brought together the best and the brightest veterinary oncologists across the Colorado Front Range to network and strengthen relationships.

This group serves patients across the region and often refers clinical trial patients to the Flint Animal Cancer Center. We're grateful for their collaboration, and we're honored to work alongside them.

Happy Clinical Trials Tuesday! One of the most common questions we get from clients is whether there are any diets that are recommended for their pets who have been diagnosed with cancer. To help answer this question, we are enrolling dogs in a study evaluating a novel cancer diet in dogs undergoing daily, definitive radiation therapy. Dogs will be randomized to receive either the novel diet or a control diet, and a variety of factors will be evaluated to assess if the diet formulated for dogs with cancer provides a benefit. More information is available on our website: https://www.csuanimalcancercenter.org/clinical-trial/observational-study-of-a-novel-canine-cancer-diet/

Novel Canine Cancer Diet Clinical Trial | CSU Vet School This Novel Canine Cancer Diet clinical trial is studying if a novel diet formulated to help nourish dogs fighting cancer is beneficial.

We dare you to look at these pictures and keep a straight face! 😃

Traveler is a lovable Rottweiler who underwent radiation therapy for oral melanoma. Despite her diagnosis, Traveler is all smiles!

Today is World Cancer Survivor Day! 🎗️ 🎉

We celebrate the incredible pets and people who have beaten the odds against this horrible disease!

Every cancer survivor reminds us why research matters. At the Flint Animal Cancer Center, we're working to create more survivor stories through groundbreaking research, innovative treatments, and discoveries that improve outcomes for pets and humans facing cancer.

Together, we're turning hope into progress – and progress into more survivors.

Happy Survivors Day!

Lucky to Live 💚 🍀

Lucky is a smiley 12-year-old Welsh Corgi, beloved by his family. Lucky was diagnosed with an oral mass and underwent surgery to remove the tumor. His family received a patient assistance grant to help cover the cost of his care. Lucky’s owner wrote –

“Lucky is doing great! I want to thank everyone for their financial help in this journey with him. It has meant so much to us, and words can't really express our gratitude for helping us!

“The staff have been terrific and understanding. Dr. Rodriguez provided the utmost care for Lucky. Again, thank you all for your kindness and concern for our doggy!!”

- Diane C., Lucky's Owner

With your support, we can ensure that pets like Lucky get a fighting chance. Give today: https://www.csuanimalcancercenter.org/give-to-patient-assistance/

Happy Clinical Trials Tuesday! We are still looking for dogs with the diagnosis of soft tissue sarcoma for enrollment in a trial. This study is testing the safety and anti-cancer activity of a form of immunotherapy called CAR T cells that are targeting a protein that is expressed on the tumor cells. You can learn more about this study here: https://www.csuanimalcancercenter.org/clinical-trial/clinical-testing-of-canine-t-cells-engineered-to-target-osteosarcoma-and-soft-tissue-sarcoma-in-combination-with-oral-immunotherapy/

Clinical Testing of Canine T cells | Cancer Clinical Trial Clinical Testing of Canine T cells clinical trial at the Flint Animal Cancer Center at Colorado State University.

Make a difference during 🐾 🔬

Cancer Research Month may be coming to an end, but the work to understand, treat, and ultimately outpace cancer never stops.

At the Flint Animal Cancer Center, every day is dedicated to advancing discoveries that improve outcomes for pets with cancer — and contribute to breakthroughs that benefit both veterinary and human medicine.

Help drive this work forward – make a gift today. Your support directly fuels research that leads to better diagnostics, more effective treatments, and renewed hope for families facing cancer.

Donate here: https://www.csuanimalcancercenter.org/give-to-research/

Thank you for being part of the effort to keep cancer research moving forward — all year long.

Thanks, Vet Specialists, for sharing Oban's story! 💚👏

When 13-year-old Oban was diagnosed with oral malignant melanoma, his family turned to the veterinary oncology specialists at CSU Animal Cancer Center for guidance. Through access to innovative clinical trials and the expertise of Board-Certified Veterinary Oncologists, Oban received advanced treatment options that helped him continue enjoying outdoor adventures with his family.

Read the full story: https://buff.ly/pJdBLzo

Spotlight: Combination Mast Cell Tumor Treatment

Dr. Kristen Weishaar, Director of Clinical Trials at the FACC, is working to create better treatment options for dogs with mast cell tumors.

While surgery remains the mainstay of treatment for most MCT, a subset has a high potential for eventual recurrence and metastasis.

With funding from the Dr. Larry and Ann Laiks Charitable Trust, Dr. Weishaar launched a clinical trial studying a new combination therapy using the immunotherapy drug gilvetmab and the cancer treatment toceranib phosphate (TOC). The hope is that this approach will improve treatment response and offer a more effective option for dogs facing aggressive mast cell tumors.

Advancing treatment options and improving outcomes is the direct result of cancer research. We're grateful to all the researchers who innovate new ideas and push the bounds of what's possible.